Page last updated: 2024-12-09

ethyl trifluoropyruvate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID2737239
SCHEMBL ID166910
MeSH IDM0501397

Synonyms (33)

Synonym
LS-13035
ethyl 3,3,3-trifluoropyruvate, 97%
ethyl trifluoropyruvate ,
AKOS005063330
13081-18-0
trifluoropyruvic acid ethyl ester
T1434
ethyl 3,3,3-trifluoro-2-oxopropanoate
ethyl 3,3,3-tris(fluoranyl)-2-oxidanylidene-propanoate
3,3,3-trifluoro-2-oxopropanoic acid ethyl ester
A806153
ethyl 3,3,3-trifluoropyruvate
3,3,3-trifluoro-2-oxopropionic acid ethyl ether
FT-0626249
ethyltrifluoropyruvate
AM61327
propanoic acid, 3,3,3-trifluoro-2-oxo-, ethyl ester
FD2022
SCHEMBL166910
ethyl trifluorpyruvate
ethyl 3,3,3 trifluoropyruvate
ethyl-trifluoropyruvate
ethyl-3,3,3-trifluoro-2-oxopropanoate
DTXSID50371934
1,2-diphenyl-1-4-2-(dimethylamino)ethoxyphenylbutane-1,4-diol
c5h5f3o3
J-005881
J-521357
F0001-0412
mfcd00114935
CS-W002381
EN300-86358
ethyl3,3,3-trifluoro-2-oxopropanoate
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (8)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (25.00)29.6817
2010's4 (50.00)24.3611
2020's2 (25.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 20.13

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index20.13 (24.57)
Research Supply Index2.20 (2.92)
Research Growth Index4.70 (4.65)
Search Engine Demand Index15.26 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (20.13)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other8 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]